Cargando…
Lung Inflammation Predictors in Combined Immune Checkpoint-Inhibitor and Radiation Therapy—Proof-of-Concept Animal Study
Purpose: Combined radiotherapy (RT) and immune checkpoint-inhibitor (ICI) therapy can act synergistically to enhance tumor response beyond what either treatment can achieve alone. Alongside the revolutionary impact of ICIs on cancer therapy, life-threatening potential side effects, such as checkpoin...
Autores principales: | Spieler, Benjamin, Giret, Teresa M., Welford, Scott, Totiger, Tulasigeri M., Mihaylov, Ivaylo B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138533/ https://www.ncbi.nlm.nih.gov/pubmed/35625911 http://dx.doi.org/10.3390/biomedicines10051173 |
Ejemplares similares
-
Toward prediction of abscopal effect in radioimmunotherapy: Pre-clinical investigation
por: Mihaylov, Ivaylo B., et al.
Publicado: (2021) -
Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedside
por: Montoya, Chris, et al.
Publicado: (2023) -
Abscopal effect observed in visceral and osseous metastases after liver SBRT in combination with nivolumab and relatlimab for sinonasal mucosal melanoma—a case report
por: Cerbon, Danielle, et al.
Publicado: (2023) -
Targeted Therapy Development in Acute Myeloid Leukemia
por: Totiger, Tulasigeri M., et al.
Publicado: (2023) -
Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept
por: Aminu, Muhammad, et al.
Publicado: (2023)